Non-invasive Markers of Liver Fibrosis: Adjuncts or Alternatives to Liver Biopsy? - Wikidata - awgldk - TriplyDB

Non-invasive Markers of Liver Fibrosis: Adjuncts or Alternatives to Liver Biopsy?

Non-invasive Markers of Liver Fibrosis: Adjuncts or Alternatives to Liver Biopsy?

http://www.wikidata.org/entity/Q26744631

about

Screening for hepatocellular carcinoma: patient selection and perspectives Fibrosis assessment in patients with chronic hepatitis B virus (HBV) infection.Clinical significance of preoperative liver stiffness measurements in primary HBV-positive hepatocellular carcinoma.PRO-C3: a new and more precise collagen marker for liver fibrosis in patients with chronic hepatitis C.Hepatic iron is the major determinant of serum ferritin in NAFLD patients.Quantitative assessment of hepatic fibrosis in chronic hepatitis B and C: T1 mapping on Gd-EOB-DTPA-enhanced liver magnetic resonance imaging.von Willebrand factor is a useful biomarker for liver fibrosis and prediction of hepatocellular carcinoma development in patients with hepatitis B and C

P2860

Q30355713-EB6B13FB-AFD5-44AE-8E59-7F9330EF466E Q30362068-48B50E89-BDE4-42BC-B0BD-E4EEA55B16A6 Q47571278-921BEC5E-C5E9-4C24-8531-249EBA1AC4F7 Q47600533-7368A2F3-83DF-4F32-AF27-BEFB4C4D2C16 Q48173674-16D2BCCE-8410-40FB-AA12-CA1137953A56 Q55010500-77D61E65-12F1-4F93-9964-F3C142432429 Q58579645-9C9397B8-4997-4491-AAB7-C06D3463DDD6

P2860

Non-invasive Markers of Liver Fibrosis: Adjuncts or Alternatives to Liver Biopsy?

http://www.wikidata.org/entity/Q26744631

description

2016 nî lūn-bûn

@nan

2016 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Non-invasive Markers of Liver Fibrosis: Adjuncts or Alternatives to Liver Biopsy?

@ast

Non-invasive Markers of Liver Fibrosis: Adjuncts or Alternatives to Liver Biopsy?

@en

Non-invasive Markers of Liver Fibrosis: Adjuncts or Alternatives to Liver Biopsy?

@nl

type

label

Non-invasive Markers of Liver Fibrosis: Adjuncts or Alternatives to Liver Biopsy?

@ast

Non-invasive Markers of Liver Fibrosis: Adjuncts or Alternatives to Liver Biopsy?

@en

Non-invasive Markers of Liver Fibrosis: Adjuncts or Alternatives to Liver Biopsy?

@nl

prefLabel

Non-invasive Markers of Liver Fibrosis: Adjuncts or Alternatives to Liver Biopsy?

@ast

Non-invasive Markers of Liver Fibrosis: Adjuncts or Alternatives to Liver Biopsy?

@en

Non-invasive Markers of Liver Fibrosis: Adjuncts or Alternatives to Liver Biopsy?

@nl

P1433

Q26744631-A1B9F082-FCEA-44AE-9110-7727A1D3B839

P1476

Q26744631-812B3CD7-4F7B-4CC4-BDE9-7EF803B1D1D1

P2093

Q26744631-0C6435F0-0409-4A3E-ACB2-F51617D264B1

Q26744631-359D7B69-4D56-405A-A637-DAF45974F520

Q26744631-3EEDB87B-5773-4807-AF44-EE4D65C207CC

P2860

Q26744631-0021A89A-18D0-453C-9CFC-EC4986458E73

Q26744631-01BE8C59-0B1B-4C69-AB2C-FFC64C9B793E

Q26744631-03A5864F-72D0-45EF-B084-1D9A69F9FB89

Q26744631-04216E48-D261-45C0-9914-D9EAEAD2D285

Q26744631-04263C5F-CFF6-43F5-AFF7-905F4FADB89C

Q26744631-05A762A3-3B0C-4882-98E0-CB2E46935F3F

Q26744631-0786C823-14FE-42BF-97F2-8369B47B7FC6

Q26744631-08A786F5-9FC0-4469-914C-48C6CA8EED67

Q26744631-08EFA189-3EA2-4A35-B63E-006416A3725D

Q26744631-0A4DA6E8-4771-4736-9F55-6A24F94B5E85

P304

Q26744631-54E3CBC6-89A9-46E6-8E7D-0CA19F8E380B

P31

Q26744631-279D8F65-C9BD-4F91-B097-8D05249FB4A7

P3181

Q26744631-87C6DC08-A687-4119-BBC4-0235E629F3ED

P356

Q26744631-ACFE7BD9-B80B-434C-BD99-CBC3CCFC4CA6

P407

Q26744631-1D4BD77A-5914-4547-8234-7B45A04F0CD0

P478

Q26744631-19C81448-C210-4F0C-A7C8-9BA35865CB04

P50

Q26744631-D6FC9BD4-5345-465C-8111-BAD79C764AD1

P577

Q26744631-D3719980-5848-44AF-95E0-0FDD461E4D39

P698

Q26744631-13B64C75-CA26-49ED-87A3-B8CA53CA4FDC

P921

Q26744631-A2CAEA16-C0C6-4157-A203-735BDE18F769

P932

Q26744631-E0A59E6E-1285-4848-8CE9-4A1396356685

P3181

P356

FPHAR.2016.00159

P1433

Frontiers in Pharmacology

P1476

Non-invasive Markers of Liver Fibrosis: Adjuncts or Alternatives to Liver Biopsy?

@en

P2093

Ahmad Moolla

http://www.w3.org/2001/XMLSchema#string

John D Ryan

http://www.w3.org/2001/XMLSchema#string

Jun L Chin

http://www.w3.org/2001/XMLSchema#string

P2860

3D molecular MR imaging of liver fibrosis and response to rapamycin therapy in a bile duct ligation rat model

Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease

Biomarkers in nonalcoholic fatty liver disease

Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers

Serum collagen type IV for the assessment of fibrosis and resistance to interferon therapy in chronic hepatitis C

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease.

Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data.

Shear-wave elastography for the estimation of liver fibrosis in chronic liver disease: determining accuracy and ideal site for measurement

Acoustic Radiation Force Impulse Elastography for the Non-Invasive Evaluation of Hepatic Fibrosis in Non-Alcoholic Fatty Liver Disease Patients: A Systematic Review & Meta-Analysis.

P304

159

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

656718

http://www.w3.org/2001/XMLSchema#string

P356

10.3389/FPHAR.2016.00159

http://www.w3.org/2001/XMLSchema#string

P407

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Michael Pavlides

P577

2016-06-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27378924

http://www.w3.org/2001/XMLSchema#string

P921

P932

4913110

http://www.w3.org/2001/XMLSchema#string